Literature DB >> 24318694

Should anaesthetists stop infusing isotonic saline?

R G Hahn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24318694     DOI： 10.1093/bja/aet292

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  6 in total

Review 1.  0.9% NaCl (Normal Saline) - Perhaps not so normal after all?

Authors:  Neil Blumberg; Jill M Cholette; Anthony P Pietropaoli; Richard Phipps; Sherry L Spinelli; Michael P Eaton; Suzie A Noronha; Jerard Seghatchian; Joanna M Heal; Majed A Refaai
Journal:  Transfus Apher Sci       Date:  2018-02-21       Impact factor: 1.764

2.  Hyperchloremia and moderate increase in serum chloride are associated with acute kidney injury in severe sepsis and septic shock patients.

Authors:  Bandarn Suetrong; Chawika Pisitsak; John H Boyd; James A Russell; Keith R Walley
Journal:  Crit Care       Date:  2016-10-06       Impact factor: 9.097

3.  An increased chloride level in hypochloremia is associated with decreased mortality in patients with severe sepsis or septic shock.

Authors:  Hyung Jung Oh; Seung Jun Kim; Yong Chan Kim; Eun Jin Kim; In Young Jung; Dong Hyun Oh; Su Jin Jeong; Nam Su Ku; Sang Hoon Han; Jun Yong Choi; Young Goo Song; Dong-Ryeol Ryu; June Myung Kim
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

4.  Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs.

Authors:  Sophie Hammond; Andrew Wignell; Paul Cooling; David A Barrett; Patrick Davies
Journal:  Intensive Care Med Exp       Date:  2020-06-23

5.  The effects of Plasma-Lyte 148 solution on blood coagulation: an in-vitro, volunteer study using rotational thromboelastometry.

Authors:  Hyun-Jung Shin; Hee-Yeon Park; Hyo-Seok Na; Jung-Pyo Hong; Gwan-Woo Lee; Sang-Hwan Do
Journal:  Blood Coagul Fibrinolysis       Date:  2018-07       Impact factor: 1.276

Review 6.  Hyperchloraemia in sepsis.

Authors:  Christos Filis; Ioannis Vasileiadis; Antonia Koutsoukou
Journal:  Ann Intensive Care       Date:  2018-03-27       Impact factor: 6.925
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.